Vicc
-
Imagining Wholeness uplifts experiences of cancer and community through the expressive arts
Imagining Wholeness is a culminating showcase of works of expressive art created by participants in the Express Yourself writing workshops at Vanderbilt-Ingram Cancer Center and in visual art workshops hosted collaboratively by the Curb Center and Gilda’s Club Middle Tennessee. Read MoreMay 20, 2024
-
Wilson awarded Komen breast cancer research grant
An engineering professor has received financial support from Susan G. Komen for breast cancer research. His project is among 60 grants totaling $26 million awarded to researchers nationwide. Those initiatives are focused on improving outcomes for metastatic breast cancer, reducing disparities in survivorship and developing new, more effective treatments. John T. Wilson, assistant professor of... Read MoreSep 25, 2019
-
Investigators map genomic landscape of very rare cancer
A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer. Read MoreFeb 28, 2019
-
Discovery of new “checkpoint” points to new cancer immunotherapy option
An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer. Read MoreFeb 21, 2019
-
Research explores link between stem cell transplant, diabetes
Brian Engelhardt is studying why as many as 50 percent of stem cell transplant recipients develop diabetes. Read MoreJan 17, 2019
-
VICC joins other major cancer centers in HPV vaccine campaign
In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer. Read MoreFeb 4, 2016
-
Obituary: Todd Jackson, BA’96, EMBA’08, ‘We Have to Be the Change’
In 2003, Todd Jackson was diagnosed with a brain tumor that was surgically removed and followed by 30 doses of radiation therapy. Last year another cancer, this time a grade IV brain cancer, surfaced, and Jackson died June 9, 2014, at age 40 in Nashville. During the decade between diagnoses, he did his best to ensure that researchers have the resources to create innovative cancer therapies. Read MoreSep 26, 2014
-
VUMC oncology programs recognized
Becker’s Hospital Review has named Vanderbilt University Medical Center among the “100 Hospitals and Health Systems With Great Oncology Programs.” Read MoreAug 7, 2014
-
Franklin Women’s Center to offer bone tests, mammograms
The Vanderbilt Franklin Women’s Center at Williamson Medical Center is now offering screening mammograms and bone density tests for patients in the community. Read MoreMar 14, 2013
-
Event offers smokers free quitting lessons, screening information
Smokers who want assistance to help them kick the habit are invited to a free counseling session with a “quit-smoking” adviser, Tuesday, Feb. 26, 5:30-7:30 p.m. at Vanderbilt Health One Hundred Oaks, first floor conference room. Read MoreFeb 21, 2013
-
Seminar to help patients cope with impact of cancer treatments
Cancer patients undergoing some forms of chemotherapy often lose some or all of their hair, as well as eyebrows and eyelashes. Read MoreFeb 7, 2013
-
Vanderbilt, GE unite to study colon tumor development
Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop. Read MoreJan 31, 2013
-
For Cancer Center’s Joyce, volunteering comes naturally
Nearly every week since 1988, cancer patients and families visiting Vanderbilt University Medical Center have been able to count on a comforting routine — at least one morning per week they are greeted by the same smiling volunteer who dispenses a dose of friendship along with coffee, snacks and advice about how to navigate the sprawling Medical Center campus. Read MoreJan 31, 2013
-
Long-term effects of prostate therapies tracked
A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment. Read MoreJan 30, 2013
-
Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers
Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators. Read MoreDec 7, 2012
-
Massion named to lead Cancer Center’s Thoracic Program
Pierre Massion, M.D., associate professor of Medicine and Cancer Biology, has been named director of the Thoracic Program at Vanderbilt-Ingram Cancer Center. Read MoreNov 29, 2012
-
Nobel laureate sheds light on RNA research
There’s been an explosion in the world of RNA — the nucleic acid “copy” of DNA, Nobel laureate Phillip Sharp, Ph.D., told the crowd gathered for his Flexner Discovery Lecture. Read MoreNov 29, 2012
-
Disney TV star to headline event to raise funds for cancer research
Disney television personality Coco Jones will be the featured performer at this year’s Dunkin’ Donuts/Baskin-Robbins Family Day in Nashville. The annual T.J. Martell Foundation event, which raises funds in support of cancer research at institutions like Vanderbilt-Ingram Cancer Center, will be held Sunday, Nov. 11, from 1 to 4 p.m. at the Curb Event Center, Belmont University. Read MoreNov 8, 2012
-
Events set to bolster lung cancer research
More Tennesseans are expected to die this year from lung cancer than any other form of cancer, yet lung cancer research receives far less funding than other forms of the disease. Read MoreNov 8, 2012
-
Wiesner to lead new hereditary cancer program
Georgia Wiesner, M.D., M.S., has joined Vanderbilt-Ingram Cancer Center (VICC) as professor of Medicine and director of the newly created Clinical and Translational Hereditary Cancer Program. Read MoreOct 25, 2012